A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

NCT02849210 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinoconjunctivitis

Interventions

BIOLOGICAL: Allergovac depot with Olea europaea pollen extract

Sponsor

Roxall Medicina España S.A